Navigation Links
New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for Heart Transplant Patient Evaluation
Date:4/19/2012

s for both in-hospital and ambulatory inhaled nitric oxide systems will help address the cost, complexity and lack of portability of current treatment regimens, and potentially reach a much larger group of patients. At present, GeNO's delivery technologies are investigational and are not approved by regulatory authorities.

GeNO recently completed a 10 patient Phase 2 pilot study of NITROSYL as a diagnostic in Pulmonary Arterial Hypertension (PAH) to obtain preliminary safety and feasibility data and is currently performing a dose-escalation trial for the treatment of Pulmonary Hypertension in patients with PAH and Pulmonary Hypertension secondary to Idiopathic Pulmonary Fibrosis (PH-IPF). Additional study details can be found on http://clinicaltrials.gov/ -- ClinicalTrials.gov Identifier NCT01265888. 

ABOUT GENO LLC                                        
GeNO LLC, founded in 2006, is a privately held, advanced development-stage technology company that is developing innovative nitric oxide (NO) generation and delivery platforms to enable the true potential of inhaled nitric oxide to be realized. The company is focused on applying the new technology to deliver inhaled nitric oxide to patients in a wide variety of settings, including ambulatory and in-home use for potential chronic treatment. GeNO's NITROSYL Systems will be regulated by the FDA as new drugs with their own NDAs. These systems have been designated as Combination Products by the FDA Office of Combination Products, with the Division of Cardiovascular and Renal Products designated as the lead reviewer for GeNO's initial INDs.

ABOUT AURORA HEALTH CARE
Aurora Health Care is a not-for-profit Wisconsin based health care prov
'/>"/>

SOURCE GeNO LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PTC124 Shows Promising Activity in Cystic Fibrosis; Phase 2 Proof-of-Concept Data Published in the Lancet
2. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
3. Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures
4. Oil palm plantations are no substitute for tropical rainforests, a new study shows
5. New carbon material shows promise of storing large quantities of renewable electrical energy
6. Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents
7. Jellyfish Protein Shows Potential to Help With Memory
8. Nycomeds Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies
9. New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD
10. Interim Analysis of Top-Line Data From Phase II/III Study Shows Favorable Efficacy & Safety for Cortheras Relaxin in Acute Heart Failure
11. Potentia Pharmaceuticals Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... PRC Clinical, a full-service, ... Bay Area, will exhibit and present at the ... on March 25th and 26th in Tel Aviv, Israel. ... Israeli life science companies seeking to conduct U.S. Food ... span all phases of human trials, from Phase I ...
(Date:3/4/2015)... 4, 2015 Vegalab announced the acquisition of ... last year. As part of the acquisition, Ecowin rebranded ... continuing his role as CEO for the company,s Korea ... will work alongside Koo and oversee developments at the ... Koo founded Ecowin in 2008 ...
(Date:3/4/2015)... Massachusetts , March 4, 2015 ... präsentiert innovative Entwicklungen für Diagnostik und Therapie, Strahlendosismanagement ...   Royal Philips (NYSE: ... Europäischen Röntgenkongress 2015 (ECR) bekannt, der ... stattfindet. An den Ständen Nr. 102 ...
(Date:3/3/2015)... Experts and industry insiders from around the ... Alltech REBELation exploring innovation, inspiration and world-changing ideas in ... 31st year, Alltech’s annual international conference traditionally draws more ... to join the REBELation at an extra discount registration ... at which point the standard early registration rate will ...
Breaking Biology Technology:PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 2PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 3PRC Clinical to Present at Inaugural Outsourcing in Clinical Trials Israel Conference 2015 on March 25 and 26th in Tel Aviv 4Korean Government Program Supports Vegalab's Research and Development 2Korean Government Program Supports Vegalab's Research and Development 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... Montgomery County Facility To Create At Least 260 ... ,Governor Edward G. Rendell helped to break ground ... Almac Group, a Northern Ireland-based provider,of research, development ... Last October, Governor Rendell announced a state ...
... - Company Will Request Hearing to Present Plans for Regaining Compliance ... Peregrine Up to an ... Regain Compliance -,- Peregrine Currently Meets All Other NASDAQ Capital Market ... the $1.00 Minimum Bid Price Rule -, TUSTIN, Calif., July ...
... Genome,Sciences, Inc. (Nasdaq: HGSI ) today announced that ... results for the quarter ended June,30, 2008. These results ... after the capital markets close., (Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO ... by senior management and will be,held on Wednesday, July ...
Cached Biology Technology:Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Company's North American Headquarters 2Pennsylvania Governor Rendell Breaks Ground for Global Pharmaceutical Services Company's North American Headquarters 3Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 2Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 3Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule 4Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results 2
(Date:2/5/2015)... Conn. , Jan. 28, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... at the upcoming RedChip Global Online CEO Conference on ... Gino Pereira , CEO of NXT-ID ... its lead product, the Wocket smart wallet and its ...
(Date:1/22/2015)... , Jan. 22, 2015 Research and Markets ... "Biometrics - A Global Market Overview" report to their ... technology is to ensure that an individual is who she/he ... may make use of a person,s unique physical characteristics, such ...
(Date:1/22/2015)... 2015 Technology Showcase, Hall E -   EyeLock Inc. ... announced it will showcase its EyeLock ID technology integrated in ... of Energy,s Oak Ridge National Laboratory (ORNL) at ... iris identity authentication technology is being used to validate the ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... VANCOUVER, British Columbia -- Ecologists have long believed that ... hatched in order to spawn. But researchers at Ohio State ... -- not for Lake Erie walleye, at least. Using ... the researchers were able to calculate the percentage of walleye ...
... that will be published online on the 28th of ... team of scientists mapped and analyzed global biodiversity patterns ... to sharks and whales. The researchers found striking similarities ... biodiversity for all thirteen groups studied. These results imply ...
... medication, first isolated from the saliva of sea snails, that ... severe forms of pain as effectively as morphine but without ... current issue of Chemical & Engineering News (C&EN), ACS, weekly ... a sea snails, saliva contains chemicals that help the slow-moving ...
Cached Biology News:Ear bones reveal spawning secrets of Lake Erie walleye 2Ear bones reveal spawning secrets of Lake Erie walleye 3Ear bones reveal spawning secrets of Lake Erie walleye 4Scientists uncover global distribution of marine biodiversity 2Scientists uncover global distribution of marine biodiversity 3
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
casein kinase 2, alpha 1 polypeptide, transcript variant 2, mRNA (cDNA clone MGC:15232 IMAGE:4121882), complete cds...
UV LAMP 254 NM 8 WATT, 1 EA. Category: Nucleid Acid Detection Systems....
... SelectFX Alexa Fluor 488 Cytochrome c Apoptosis ... need to detect cytochrome c in fixed ... primary antibody and an Alexa Fluor ... dye exhibits bright green fluorescence that is ...
Biology Products: